Literature DB >> 2870029

In vivo properties of a cloned K88 adherence antigen determinant.

G Dougan, R Sellwood, D Maskell, K Sweeney, F Y Liew, J Beesley, C Hormaeche.   

Abstract

An Escherichia coli strain of serotype O9:K36:H19 harboring the K88 recombinant plasmid pMK005 was able to efficiently colonize the small bowel of young piglets after oral infection. The strain expressed K88 antigen in vivo, and bacteria were detected in close association with the surface of the intestinal villi. Mice infected orally or intravenously with attenuated Salmonella typhimurium SL3261 harboring pMK005 were well protected against subsequent challenge with the highly virulent S. typhimurium SL1344. Anti-K88 antibodies were detected in the serum of mice immunized with SL3261(pMK005).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870029      PMCID: PMC262244          DOI: 10.1128/iai.52.1.344-347.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 2.  Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains.

Authors:  W Gaastra; F K de Graaf
Journal:  Microbiol Rev       Date:  1982-06

3.  Molecular analysis of the virulence determinants of enterotoxigenic Escherichia coli isolated from domestic animals: applications for vaccine development.

Authors:  G Dougan; P Morrissey
Journal:  Vet Microbiol       Date:  1985-04       Impact factor: 3.293

Review 4.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

5.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

6.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

7.  Organization of K88ac-encoded polypeptides in the Escherichia coli cell envelope: use of minicells and outer membrane protein mutants for studying assembly of pili.

Authors:  G Dougan; G Dowd; M Kehoe
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

8.  K88ab gene of Escherichia coli encodes a fimbria-like protein distinct from the K88ab fimbrial adhesin.

Authors:  F R Mooi; M van Buuren; G Koopman; B Roosendaal; F K de Graaf
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

9.  Identification and cloning of the genetic determinant that encodes for the K88ac adherence antigen.

Authors:  P L Shipley; G Dougan; S Falkow
Journal:  J Bacteriol       Date:  1981-02       Impact factor: 3.490

10.  Expression of a cloned K88ac adhesion antigen determinant: identification of a new adhesion cistron and role of a vector-encoded promoter.

Authors:  M Kehoe; M Winther; G Dougan
Journal:  J Bacteriol       Date:  1983-09       Impact factor: 3.490

View more
  14 in total

Review 1.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

2.  Genetic characterization and virulence of enterotoxigenic Escherichia coli mutants which have lost virulence genes in vivo.

Authors:  T A Casey; H W Moon
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

Review 3.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

Review 4.  Outer membrane protein PhoE as a carrier for the exposure of foreign antigenic determinants at the bacterial cell surface.

Authors:  M Agterberg; J Tommassen
Journal:  Antonie Van Leeuwenhoek       Date:  1991-05       Impact factor: 2.271

5.  Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis.

Authors:  C A Guzmán; R M Brownlie; J Kadurugamuwa; M J Walker; K N Timmis
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers.

Authors:  J X Bao; J D Clements
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

7.  Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli.

Authors:  K Schaale; K M Peters; A M Murthy; A K Fritzsche; M-D Phan; M Totsika; A A B Robertson; K B Nichols; M A Cooper; K J Stacey; G C Ulett; K Schroder; M A Schembri; M J Sweet
Journal:  Mucosal Immunol       Date:  2015-05-20       Impact factor: 7.313

8.  Expression of heat-stable enterotoxin STb by adherent Escherichia coli is not sufficient to cause severe diarrhea in neonatal pigs.

Authors:  T A Casey; C J Herring; R A Schneider; B T Bosworth; S C Whipp
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

9.  Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors.

Authors:  D F Sigwart; B A Stocker; J D Clements
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

10.  Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells.

Authors:  M J Wick; J D Pfeifer; K A Findlay; C V Harding; S J Normark
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.